UNSPSC 51162738: Sobrerol

This classification denotes an expectorant with the molecular formula C10H18O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AI0NX02O35, chemically known as 5-hydroxy-alpha,alpha,4-trimethylcyclohex-3-ene-1-methanol but more generally known as sobrerol, which bears US NIH Compound Identifier 91463. European Medicines Agency schedules Sobrerol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15264MIG.

World Health Organization schedules sobrerol in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, SOBREROL remains US FDA's Preferred Term for this commodity. SMILES: CC1=CCC(CC1O)C(C)(C)O.

UNSPSC 51162738 Sobrerol is a Commodity code under which state and local governments procure pharmaceutical products and medical supplies, specifically parenteral solutions, intravenous products, and related healthcare commodities for correctional health systems and public health agencies. The Washington State Department of Corrections and Seminole County, Florida have recently solicited under this code for products ranging from parenteral nutrition solutions and IV fluids to naloxone and drug deactivation systems. State correctional departments and county health agencies are the primary issuing bodies, with DOC representing a significant repeat buyer managing multiple facilities across regional contracts. Work solicited includes time-sensitive pharmaceutical preparation and delivery—parenteral nutrition bags must reach correctional facilities within 24 hours of order, while other IV solutions must arrive within 8 hours—along with inventory management, cold-chain compliance, and documentation of clinical monitoring capabilities for inmate healthcare delivery.

Recent opportunities center in Washington State and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with a response deadline of October 7, 2026, seeking parenteral products and services for eight facilities across three regional zones (West, Central, and East), with the option to award up to three contractors per region and an initial contract term through June 30, 2030. DOC set aspirational participation goals for small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), requiring fixed pricing for two years and mandatory insurance including $1 million to $2 million coverage levels across general liability, professional liability, auto liability, and cyber liability. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the county community health building, though that opportunity's response deadline listed (July 26, 2023) predates the posting date and suggests a data anomaly in the source record.